Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 10, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics announces the appointment of Robert W. Azelby to its Board of Directors

Autolus Therapeutics announces the appointment of Robert W. Azelby to its Board of Directors
December 22, 2023 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Announces Changes to its Board of Directors

Autolus Therapeutics Announces Changes to its Board of Directors
December 09, 2023 20:30 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023

Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023
November 27, 2023 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Submits Biologics License Application to U.S. Food and Drug Administration for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (ALL)

Autolus Therapeutics Submits Biologics License Application to U.S. Food and Drug Administration for obecabtagene autoleucel (obe-cel)
November 15, 2023 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics to Host Analyst / Investor event at the American Society of Hematology (ASH) Annual Meeting 2023

Autolus Therapeutics to Host Analyst / Investor event at the American Society of Hematology (ASH) Annual Meeting 2023
November 06, 2023 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics announces participation in upcoming conferences

Autolus Therapeutics announces participation in upcoming conferences
November 02, 2023 09:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023 in Two Oral Presentations and Two Poster Presentations

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023
November 02, 2023 07:11 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates

Autolus Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
October 17, 2023 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics to host virtual event to discuss the company’s obe-cel program in systemic lupus erythematosus

Autolus Therapeutics to host virtual event to discuss the company’s obe-cel program in systemic lupus erythematosus
October 11, 2023 08:07 ET | Source: Autolus Therapeutics plc

Correction - Autolus Therapeutics to report third quarter 2023 financial results and host conference call on November 2, 2023

Correction - Autolus Therapeutics to report third quarter 2023 financial results and host conference call on November 2, 2023